Market Closed -
Nasdaq
01:30:00 03/05/2024 am IST
|
5-day change
|
1st Jan Change
|
14.19
USD
|
+11.38%
|
|
+16.03%
|
-4.96%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
8,340
|
17,615
|
7,795
|
7,698
|
1,595
|
1,527
|
-
|
-
|
Enterprise Value (EV)
1 |
8,312
|
17,810
|
8,148
|
8,148
|
1,923
|
1,860
|
1,761
|
1,700
|
P/E ratio
|
-1,204
x
|
865
x
|
-134
x
|
-83.4
x
|
-7.66
x
|
-9.21
x
|
-7.97
x
|
-8.63
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
23.7
x
|
35.6
x
|
14.6
x
|
14.3
x
|
3.13
x
|
2.75
x
|
2.61
x
|
2.31
x
|
EV / Revenue
|
23.7
x
|
36
x
|
15.2
x
|
15.1
x
|
3.78
x
|
3.35
x
|
3.01
x
|
2.57
x
|
EV / EBITDA
|
1,102
x
|
450
x
|
-239
x
|
-103
x
|
-8.67
x
|
-9.73
x
|
-8.75
x
|
-8.33
x
|
EV / FCF
|
515
x
|
212
x
|
139
x
|
864
x
|
-19.2
x
|
-13.6
x
|
-14
x
|
-10.3
x
|
FCF Yield
|
0.19%
|
0.47%
|
0.72%
|
0.12%
|
-5.22%
|
-7.33%
|
-7.12%
|
-9.71%
|
Price to Book
|
38.5
x
|
37.2
x
|
19
x
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
98,969
|
1,01,797
|
1,03,819
|
1,04,950
|
1,06,861
|
1,07,606
|
-
|
-
|
Reference price
2 |
84.27
|
173.0
|
75.08
|
73.35
|
14.93
|
14.19
|
14.19
|
14.19
|
Announcement Date
|
27/02/20
|
25/02/21
|
24/02/22
|
23/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
351.3
|
494.4
|
535
|
537.8
|
509.3
|
555.6
|
584.2
|
661
|
EBITDA
1 |
7.546
|
39.55
|
-34.08
|
-78.9
|
-221.9
|
-191.2
|
-201.3
|
-204.1
|
EBIT
1 |
-0.914
|
30.4
|
-44.33
|
-89.52
|
-232.9
|
-215.1
|
-220.5
|
-191.9
|
Operating Margin
|
-0.26%
|
6.15%
|
-8.29%
|
-16.64%
|
-45.72%
|
-38.72%
|
-37.75%
|
-29.03%
|
Earnings before Tax (EBT)
1 |
-8.824
|
18.1
|
-52.08
|
-81.85
|
-191.7
|
-170.1
|
-189
|
-162.5
|
Net income
1 |
-7.23
|
19.81
|
-58.35
|
-92.53
|
-207
|
-179.8
|
-198
|
-170.6
|
Net margin
|
-2.06%
|
4.01%
|
-10.91%
|
-17.2%
|
-40.65%
|
-32.36%
|
-33.89%
|
-25.81%
|
EPS
2 |
-0.0700
|
0.2000
|
-0.5600
|
-0.8800
|
-1.950
|
-1.540
|
-1.781
|
-1.644
|
Free Cash Flow
1 |
16.14
|
84.18
|
58.59
|
9.43
|
-100.4
|
-136.4
|
-125.5
|
-165
|
FCF margin
|
4.59%
|
17.03%
|
10.95%
|
1.75%
|
-19.72%
|
-24.55%
|
-21.48%
|
-24.96%
|
FCF Conversion (EBITDA)
|
213.82%
|
212.84%
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
424.98%
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
27/02/20
|
25/02/21
|
24/02/22
|
23/02/23
|
22/02/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
133.2
|
137.5
|
140.9
|
131
|
128.4
|
122.2
|
126.1
|
127.3
|
133.8
|
138.5
|
136.7
|
139
|
141.4
|
143.8
|
143.6
|
EBITDA
1 |
-20.73
|
1.804
|
-18.47
|
-21.95
|
-40.28
|
-57.53
|
-59.94
|
-55.44
|
-48.99
|
-38.7
|
-53.39
|
-52.4
|
-48.84
|
-42.87
|
-53.94
|
EBIT
1 |
-23.4
|
-0.806
|
-21.13
|
-24.61
|
-42.98
|
-60.25
|
-62.66
|
-58.24
|
-51.72
|
-41.52
|
-54.39
|
-55.58
|
-56.15
|
-45.88
|
-57.01
|
Operating Margin
|
-17.56%
|
-0.59%
|
-15%
|
-18.79%
|
-33.46%
|
-49.31%
|
-49.71%
|
-45.75%
|
-38.66%
|
-29.98%
|
-39.79%
|
-39.98%
|
-39.72%
|
-31.91%
|
-39.7%
|
Earnings before Tax (EBT)
1 |
-25.57
|
-2.515
|
-23.36
|
-23.42
|
-32.56
|
-51.08
|
-53.9
|
-48.22
|
-38.53
|
-31.64
|
-47.38
|
-47.44
|
-44.93
|
-39.51
|
-50.63
|
Net income
1 |
-26.46
|
-4.647
|
-24.01
|
-26.58
|
-37.3
|
-53.06
|
-57.42
|
-49.48
|
-47.08
|
-38.76
|
-44.74
|
-46.47
|
-47.27
|
-39.51
|
-50.63
|
Net margin
|
-19.86%
|
-3.38%
|
-17.04%
|
-20.29%
|
-29.05%
|
-43.43%
|
-45.55%
|
-38.87%
|
-35.19%
|
-27.98%
|
-32.73%
|
-33.43%
|
-33.44%
|
-27.48%
|
-35.26%
|
EPS
2 |
-0.2500
|
-0.0400
|
-0.2300
|
-0.2500
|
-0.3600
|
-0.5000
|
-0.5400
|
-0.4600
|
-0.4500
|
-0.3600
|
-0.4019
|
-0.4144
|
-0.4298
|
-0.3650
|
-0.4200
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
24/02/22
|
28/04/22
|
28/07/22
|
27/10/22
|
23/02/23
|
04/05/23
|
27/07/23
|
26/10/23
|
22/02/24
|
02/05/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
195
|
353
|
450
|
328
|
333
|
234
|
173
|
Net Cash position
1 |
27.9
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
4.936
x
|
-10.37
x
|
-5.706
x
|
-1.478
x
|
-1.741
x
|
-1.163
x
|
-0.8486
x
|
Free Cash Flow
1 |
16.1
|
84.2
|
58.6
|
9.43
|
-100
|
-136
|
-125
|
-165
|
ROE (net income / shareholders' equity)
|
-4.38%
|
5.71%
|
-13.2%
|
-21.7%
|
-51.5%
|
-68.4%
|
-153%
|
-420%
|
ROA (Net income/ Total Assets)
|
-1.77%
|
2.59%
|
-5.33%
|
-7.94%
|
-17.7%
|
-19%
|
-25.5%
|
-19.3%
|
Assets
1 |
409.6
|
765.7
|
1,096
|
1,166
|
1,169
|
944.2
|
776.1
|
882.9
|
Book Value Per Share
|
2.190
|
4.660
|
3.950
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
10.5
|
15
|
24.2
|
21.4
|
27.1
|
25
|
29.5
|
42
|
Capex / Sales
|
2.98%
|
3.03%
|
4.52%
|
3.97%
|
5.32%
|
4.5%
|
5.05%
|
6.35%
|
Announcement Date
|
27/02/20
|
25/02/21
|
24/02/22
|
23/02/23
|
22/02/24
|
-
|
-
|
-
|
Last Close Price
14.19
USD Average target price
25.57
USD Spread / Average Target +80.21% Consensus |
1st Jan change
|
Capi.
|
---|
| -4.96% | 1.37B | | +73.17% | 12.37B | | -18.08% | 7.96B | | +16.24% | 7.09B | | +3.39% | 5.83B | | +11.77% | 5.35B | | +29.65% | 4.63B | | -17.74% | 4B | | -35.34% | 2.41B | | +2.10% | 2B |
Medical Equipment
|